Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CNM-AgZn17
- Development stage
- Preclinical
- Lead developer
- Clene
- Modality
- Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Topical
01
Overview
CNM-AgZn17 is a topical gel polymer suspension composed of **silver and zinc ions**. It is being developed as a broad-spectrum anti-infective agent for the treatment of infectious diseases and for accelerating wound healing. The drug leverages the antimicrobial properties of silver and zinc ions, which are known to inhibit a wide range of bacterial and viral pathogens, including antibiotic-resistant strains. In preclinical studies, CNM-AgZn17 has demonstrated robust antiviral and antibacterial activity. The drug is in the preclinical or early-phase development stage and is positioned for topical application in clinical scenarios that require rapid infection control or enhanced tissue repair. CNM-AgZn17 is being developed by Clene[1][3][5][7][8][10][11][13][14].
- Brand names
- CNM-AgZn17CNM-AgZn-17CNM-AgZn 17
- Other names
- CNM-AgZn17CNM-AgZn-17CNM-AgZn 17
02
Targets
Chitin
Beyond the preview
Go deeper on CNM-AgZn17.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CNM-AgZn17.